ANI Pharmaceuticals, Inc. Launches Carbamazepine Extended-Release Capsules

Published: 2026-04-13 16:16:15 ET ANIP

Published on 04/13/2026 at 04:16 pm EDT

ANI Pharmaceuticals, Inc. announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg and 300 mg. ANI?s Carbamazepine Extended-Release Capsules are the generic version of the reference listed drug (RLD) Carbatrol®. U.S. annual sales for Carbamazepine Extended-Release Capsules total approximately $65 million, based on February 2026 moving annual total (MAT) IQVIA data.